Financial Results
Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports Its Financial Results (Consolidated) for The Period From 01/01/2026 to 31/03/2026
Published at 17 May 2026 at 10:45المصرية الدولية للصناعات الدوائية - ايبيكو
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name: Egyptian International Pharmaceuticals (EIPICO)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Consolidated) Period: From 01/01/2026 to 31/03/2026
Net profit: 284,419,447
F/S (Consolidated) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 318,741,936
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
Taking minority rights into consideration
The BoD Report in Arabic (290 KB)
The BoD Report in English (137 KB)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Consolidated) Period: From 01/01/2026 to 31/03/2026
Net profit: 284,419,447
F/S (Consolidated) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 318,741,936
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
Taking minority rights into consideration
The BoD Report in Arabic (290 KB)
The BoD Report in English (137 KB)